Jeffrey A. Lieberman

Effectiveness of Antipsychotic Drugs in Patients with Chronic Schizophrenia

How mental health care should change as a consequence of the COVID-19 pandemic

Relationship Between Duration of Untreated Psychosis and Outcome in First-Episode Schizophrenia: A Critical Review and Meta-Analysis

Predictors of Relapse Following Response From a First Episode of Schizophrenia or Schizoaffective Disorder

Effectiveness of Atypical Antipsychotic Drugs in Patients with Alzheimer's Disease

Prevalence of the metabolic syndrome in patients with schizophrenia: Baseline results from the Clinical Antipsychotic Trials of Intervention Effectiveness (CATIE) schizophrenia trial and comparison with national estimates from NHANES III

Clozapine-Induced Agranulocytosis -- Incidence and Risk Factors in the United States

Neuropsychology of First-Episode Schizophrenia: Initial Characterization and Clinical Correlates

Duration of psychosis and outcome in first-episode schizophrenia

Brain volume in first-episode schizophrenia

Physical Health Monitoring of Patients With Schizophrenia

Catching Up on Schizophrenia